Government Strives to Reduce Dependence on Imported Pharmaceutical Raw Materials

Published 2026-10-20

The Indonesian government, through the National Agency of Drug and Food Control (BPOM) and the Ministry of Health, is currently working hard to strengthen the domestic pharmaceutical industry. This step was taken in response to Indonesia's high dependence on imported pharmaceutical raw materials, which currently still reaches 90 percent.

This high dependence on foreign products is considered a major challenge for national health security. So far, most of the chemicals needed to produce medicines in Indonesia must be brought in from other countries, which makes drug prices less stable and vulnerable to global supply chain disruptions.

To address this issue, the government has identified three main challenges in the health sector that hinder the independence of the local pharmaceutical industry. The current main focus is to improve the production ecosystem so that pharmaceutical companies in Indonesia are able to produce their own raw materials with high quality standards.

Strengthening this local industry is expected to gradually reduce import figures over the next few years. By producing raw materials domestically, the government is optimistic that drug prices will become more affordable for the wider community and the availability of drug stocks in hospitals and pharmacies will be more guaranteed.

This strategic step is a national priority to create independence in the health sector. The government is committed to continuing to provide support to local pharmaceutical industry players so that they can compete and meet the need for medicines for all Indonesian people.

Sources: Suara Pemerintah

More Indonesia news

All Indonesia news · News by country